Research Grant
[Cite as https://purl.org/au-research/grants/nhmrc/GNT1145295]
Researchers:
Prof Jeffrey Keelan
(Principal investigator)
,
A/Pr Matthew Kemp
,
Dr Hayley Dickinson
,
Dr Stacey Ellery
,
Prof David Olson
View all 6 related researchers
Brief description Interleukin-1 (IL-1) is a potent inflammatory protein involved in many inflammatory disorders, including preterm birth (PTB). Blocking the actions of IL-1 in pregnancies at risk of delivering preterm may protect the fetus from PTB and the long-term harm of exposure to inflammation before birth. Using four different models of antenatal inflammation, we will explore the use of a new IL-1 inhibitor to see if it blocks inflammation ‘in utero’ and improve neonatal health and development.
Funding Amount $1,377,827.00
Funding Scheme Project Grants
Notes Standard Project Grant
- nhmrc : GNT1145295
- PURL : https://purl.org/au-research/grants/nhmrc/GNT1145295